PharmGKB.ID,Variant,Literature,Genes,Association,Significance,P.Value,X..of.Cases,X..of.Controls,Biogeographical.Groups,Phenotype.Categories,Pediatric,More.Details,Drugs,Allele,Effect,PLQ,CHG,ATQCES,CLM,ATQPGC
1452288920,rs776746,PMID:37891021,CYP3A5,Allele T is associated with increased likelihood of Diabetes Mellitus when treated with tacrolimus in people with Kidney Transplantation as compared to allele C.,yes,0.015,44,200,East Asian,Toxicity,false,"Alleles complemented. ""the frequency of the A allele was significantly higher in the PTDM group compared to the control group, whereas the G allele was more prevalent in the control group""",tacrolimus,T,increased,0.85,0.64,0.22,,0.25
1447679323,rs2167270,PMID:26282401,LEP,Allele A is associated with increased likelihood of Diabetes Mellitus when treated with cyclosporine or tacrolimus in people with Kidney Transplantation as compared to allele G.,yes,0.000035,229,NA,European,Toxicity,false,This was more significant in the subset of tacrolimus-treated patients but not significant in the smaller subset of cyclosporine-treated patients.,cyclosporine; tacrolimus,A,increased,0.7,0.44,0.14,0.314,
1296666368,rs3792269,PMID:25327507,CAPN10,Allele G is associated with decreased response to metformin in people with Diabetes Mellitus as compared to allele A.,yes,0.02,144,NA,Unknown,Efficacy,false,Treatment success was defined as 1) achieving HbA1c <7 % and 2) absolute reduction in HbAlc after 6-months of metformin therapy. The relationships between genotypes and outcomes were evaluated using multivariate logistic and linear models.,metformin,G,decreased,,,,,
1448602371,rs11124945,PMCID:PMC5368017,PLEKHH2,Allele G is associated with decreased risk of Diabetes Mellitus when exposed to atenolol or verapamil in people with Hypertension as compared to allele A.,yes,0.000000858,138,414,European,Toxicity,false,,atenolol; verapamil,G,decreased,,,,,
1183681016,rs7917983,PMCID:PMC3893755,TCF7L2,Allele T is associated with increased risk of Diabetes Mellitus when treated with hydrochlorothiazide in people with Hypertension as compared to allele C.,yes,0.03,941,494,European,Toxicity,false,Hydrochlorothiazide-induced diabetes. Hydrochlorothiazide (HCTZ)  treatment was defined as exposure to HCTZ with any dose or duration before diagnosis of NOD. The patients are part of the INVEST study with randomized treatment with either an atenolol-based or a verapamil sustained release (SR)-based antihypertensive strategy. Both treatment strategies included the possibility of HCTZ treatment at different steps of the treatment plan for BP control as necessary.,hydrochlorothiazide,T,increased,0.12,0.25,0.67,0.52,0.52
981754621,rs7903146,PMCID:PMC2799180,TCF7L2,"Allele T is associated with increased likelihood of Diabetes Mellitus when treated with cyclosporine, sirolimus or tacrolimus in people with Kidney Transplantation as compared to allele C.",yes,0.002,1076,NA,European,Toxicity,false,"The type of Diabetes is termed ""NODAT"" (New-onset diabetes after transplantation).  Authors state that correction for multiple testing was not done because the SNPs were selected on the basis of biological evidence that they were associated with type 2 Diabetes. 11 polymorphisms were tested, and p shown is uncorrected value.  CT compared to CC: 59% higher odds of NODAT (p = 0.03).  TT vs CC: 92% higher odds of NODAT (p = 0.04).",cyclosporine; sirolimus; tacrolimus,T,increased,0.659,0.27,0.224,0.239,0.222
981344247,rs675388,PMCID:PMC3529742,KCNJ1,Allele A is associated with increased likelihood of Diabetes Mellitus when treated with hydrochlorothiazide in people with Hypertension as compared to allele G.,yes,0.004,131,NA,African American/Afro-Caribbean,Toxicity,false,,hydrochlorothiazide,A,increased,0.562,0.175,0.052,0.085,0.106
981344236,rs658903,PMCID:PMC3529742,KCNJ1,Allele A is associated with decreased likelihood of Diabetes Mellitus when treated with hydrochlorothiazide in people with Hypertension as compared to allele T.,yes,0.002,464,NA,Latino,Toxicity,false,"Caution: this is a A/T SNP in a gene on the minus chromosomal strand. In the paper association is given for the A (minor) allele, which appears to be already shown on the plus chromosomal strand.",hydrochlorothiazide,A,decreased,0.5,,,0.08,
1448276427,rs4149056,PMID:27271184,SLCO1B1,Allele C is associated with increased response to rosiglitazone in people with Diabetes Mellitus as compared to allele T.,yes,0.04,444,NA,Unknown,Efficacy,false,as measured by HbA1c reduction.,rosiglitazone,C,increased,0.5,0.045,0.188,0.181,0.192
981344223,rs11600347,PMCID:PMC3529742,KCNJ1,Allele A is associated with increased likelihood of Diabetes Mellitus when treated with hydrochlorothiazide in people with Hypertension as compared to allele C.,yes,0.008,371,NA,European,Toxicity,false,"The association is described as ""nominal significance"" in hispanics.",hydrochlorothiazide,A,increased,0.5,0.01,0.045,0.176,0.135
1452828220,rs622342,PMID:39375343,SLC22A1,Allele A is associated with increased response to metformin in people with Diabetes Mellitus as compared to allele C.,yes,0.0013,292,NA,European,Efficacy,false,"Among the tested variants, only rs622342 in SLC22A1 (variously also referred to as ""SLC2A1"" in the publication) was significantly associated with lower HbA1c in type II diabetes mellitus patients using metformin. Given the nucleotide base description of rs622342 in Table S1 as ""C>A"", it was assumed that A is the risk allele.",metformin,A,increased,0.926,0.785,0.571,0.521,0.624
1447987173,rs7754840,PMCID:PMC4854407,CDKAL1,Allele C is associated with increased response to Dipeptidyl peptidase 4 (DPP-4) inhibitors in people with Diabetes Mellitus as compared to allele G.,yes,0.01,426,NA,East Asian,Efficacy,false,"The SNP was significantly associated with improved response to DPP-4 inhibitors (as assayed by reductions in HbA1c). Most of the patients were on combination anti-diabetic agent (ADA) therapy, but the relationship was only significant for regimens that included DPP-4 (alone or in combination with other ADAs).",Dipeptidyl peptidase 4 (DPP-4) inhibitors,C,increased,0.761,0.561,0.25,0.303,0.301
981344210,rs12795437,PMCID:PMC3529742,KCNJ1,Allele C is associated with increased likelihood of Diabetes Mellitus when treated with hydrochlorothiazide in people with Hypertension as compared to allele G.,yes,0.006,371,NA,European,Toxicity,false,"Caution: this is a C/G SNP in a gene on the minus chromosomal strand. In the paper association is given for the C (minor) allele, which appears to be already shown on the plus chromosomal strand. 
The association is described as ""nominal significance"" in hispanics",hydrochlorothiazide,C,increased,0.5,,0.071,0.181,0.134
1446903431,rs7541245,PMCID:PMC4525256,FMO5,Allele A is associated with decreased response to metformin in people with Diabetes Mellitus as compared to allele C.,yes,0.00188,258,NA,Unknown,Efficacy,false,EHR-linked and EHR-based phenotyping methods were used to study common variants within FMO5. Efficacy was assessed by A1c levels extracted from EHR records.,metformin,A,decreased,0.5,0.075,,0.032,0.039
1447987188,rs7756992,PMCID:PMC4854407,CDKAL1,Allele G is associated with increased response to Dipeptidyl peptidase 4 (DPP-4) inhibitors in people with Diabetes Mellitus as compared to allele A.,yes,0.001,426,NA,East Asian,Efficacy,false,"The SNP was significantly associated with improved response to DPP-4 inhibitors (as assayed by reductions in HbA1c). Most of the patients were on combination anti-diabetic agent (ADA) therapy, but the relationship was only significant for regimens that included DPP-4 (alone or in combination with other ADAs).",Dipeptidyl peptidase 4 (DPP-4) inhibitors,G,increased,0.64,0.59,0.059,0.266,0.319
1448569497,rs62151109,PMID:28084903,CLASP1,"Allele C is associated with increased likelihood of Cough when treated with Ace Inhibitors, Plain in people with Asthma, Diabetes Mellitus, Heart Failure, Hypertension and Pulmonary Disease, Chronic Obstructive as compared to allele T.",no,0.0000000944,124,1345,European,Toxicity,false,No SNPs in the GWAS met the threshold for Bonferroni correction but this had the strongest association. Assumed that minor allele is the risk allele.,"Ace Inhibitors, Plain",C,increased,,,,,
1448256681,rs8192675,PMCID:PMC5007158,SLC2A2,Allele C is associated with increased response to metformin in people with Diabetes Mellitus as compared to allele T.,yes,0.000000026,10577,NA,European,Efficacy,false,"The C allele of rs8192675 was associated with a 0.17% (P = 6.6 Ã— 10-14) greater metformin-induced reduction in hemoglobin A1c (HbA1c) in 10,577 participants of European ancestry.",metformin,C,increased,0.766,0.62,0.363,0.356,
